chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in my arm, by my arm pit/chest, shoulder and back by my arm pit; Pain in my arm, by my arm pit/chest, shoulder and back by my arm pit; Pain in my arm, by my arm pit/chest, shoulder and back by my arm pit; Pain in my arm, by my arm pit/chest, shoulder and back by my arm pit; This is a spontaneous report from a contactable consumer, the patient. A 80-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11Jan2021 at 00:00 (at the age of 80-years-old) as a single dose and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Feb2021 at 10:00 (at the age of 80-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously took codeine (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. Concomitant medications taken within two weeks of vaccination included tocopherol (VITAMIN E), fish oil (MANUFACTURER UNKNOWN), lorazepam 1 milligram (MANUFACTURER UNKNOWN) and ascorbic acid, vitamin d nos (ASCORBIC ACID; VITAMIN D NOS) (reported as vitamin C with D), all taken for unknown indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jan2021, the patient experienced pain in arm, by her arm pit/chest, shoulder and back by her arm pit. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events pain in arm, by her arm pit/chest, shoulder and back by her arm pit was not resolved, at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Later that evening pt. developed moderate conj. injection in both eyes - seen in office 2/12/18. Dx'd with bacterial conj. Tx with tobramycin eye drops. On 2/23/18, he developed hives, went to ER was treated. On 3/5/18 developed swollen tonsils and fatigue, was seen in ER.
Patient was given first dose of pediatric Pfizer despite being over 12 years old. No adverse symptoms after follow up with mom 72 hours later. Only reported muscle soreness at the site of the deltoid- consistent with normal symptoms following COVID-19 Vaccine.
Patient called 7/8/11 and told RPh on duty still having residual pain from ZOSTAVAX injection given on 5/28/11; was told to F-up w/MD and pt. said he had and she requested him to get a MRI.
Since the first shot I've been experiencing some fatigue and oversleeping .; Since the first shot I've been experiencing some fatigue and oversleeping .; This is a spontaneous report from a contactable consumer (patient).   A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8730) dose 2 via an unspecified route of administration in Arm Left on 09Apr2021 14:00 (at the age of 59 years old) as single for COVID-19 immunisation at pharmacy or drug Store. Medical history included diabetes mellitus from an unknown date and unknown if ongoing. The patient received other medications within 2 weeks of vaccination. The patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW0151) via an unspecified route of administration in Arm Right on an unspecified date as single for COVID-19 immunisation. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced as, since the first shot i've been experiencing some fatigue and oversleeping. I normally sleep 4-6 hours but now after the shot I sleep a lot more 14-18 hours daily intermittently  I thought I might sleep it off but it's taking longer than normal on 12Apr2021. Since the vaccination, the patient did not tested for COVID-19. No treatment was given. Outcome of the events were not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
have not been feeling well; headache; nausea; a clammy feeling; I also have a sore throat; occasional runny nose; a cold symptom; Arm was very sore and very tender; Arm was very sore and very tender; balance is a bit off; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on 10Mar2021 (at age 70-year-old) at single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: unknown) on 13Feb2021 at single dose for COVID-19 immunization and had sore arm. Since second dose of vaccine he was not been feeling well. He had the second dose 3 weeks ago and still have a headache and nausea every day and a clammy feeling that comes and goes. He also had a sore throat and occasional runny nose like a cold symptom. He has no underlying health issues. He does not take pharmaceuticals. His arm was very sore and very tender, he was close to be in sick, headaches on and off, his balance was a bit off, all in 2021. The outcome of events was unknown.  No follow up attempts are needed. No further information is expected.
Has not slept; Arm is frozen; Swollen; Pain; Unable to use arm; Pain is terrific; Aching; Shot went too deeply into the muscle; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Shot went too deeply into the muscle), INSOMNIA (Has not slept), MUSCULOSKELETAL STIFFNESS (Arm is frozen), PERIPHERAL SWELLING (Swollen) and PAIN (Pain) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ACETAMINOPHEN for an unknown indication.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Shot went too deeply into the muscle). On an unknown date, the patient experienced INSOMNIA (Has not slept), MUSCULOSKELETAL STIFFNESS (Arm is frozen), PERIPHERAL SWELLING (Swollen), PAIN (Pain), LIMB DISCOMFORT (Unable to use arm), PAIN (Pain is terrific) and PAIN (Aching). On 03-Mar-2021, PRODUCT ADMINISTRATION ERROR (Shot went too deeply into the muscle) had resolved. At the time of the report, INSOMNIA (Has not slept), MUSCULOSKELETAL STIFFNESS (Arm is frozen), PERIPHERAL SWELLING (Swollen), PAIN (Pain), LIMB DISCOMFORT (Unable to use arm), PAIN (Pain is terrific) and PAIN (Aching) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to US-MODERNATX, INC.-MOD-2021-060786 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Reporter contact information updated and verified. Event(Product administration error)updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060786:First dose
This spontaneous report was received from a medical assistant and refers to a multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of VAQTA,  lot number M022924, expiration date 24-JAN-2018, lot number M033611, expiration date 02-MAR-2018, (strength, dose, dose number, route and anatomical location were not reported), for prophylaxis. The temperature was between 32 and 36 Fahrenheit degrees during 7 hours, and, below 32 Fahrenheit degrees (the lowest temperature was 29 Fahrenheit degrees), during a time frame of 6 hours. The vaccines did not experience any previous temperature excursions. The digital data logger was involved. No adverse effects were reported. No product quality complain was involved. This is one of several reports from the same reporter.  Additional information has been requested.; Sender's Comments:  US-009507513-1702USA008038: US-009507513-1702USA008037: US-009507513-1702USA008035: US-009507513-1702USA005634:
Seen 7/2/18 in office and received MMR (L thigh) and PREVNAR (R thigh). Later found out that patient had received MMR, PREVNAR, VARIVAX, Hep A and Hib on 6/8/18. Dad had the paperwork from office at the visit, but did not provide it to the nurse or provider prior to receiving immunizations at well child check. Mom noted small amount of redness on right thigh at injection site on evening on 7/2/18. Yesterday the redness got larger. Mom feels a lump within the red area. Red area got yet bigger this morning. Area is tender. Yesterday developed fever to 103. MOTRIN and TYLENOL are controlling the fever.
Woke up with sore arm. By 11:30am started feeling dizzy, nauseous, chills, really tired and it came on really fast. I slept for a few hours and tried waking up then went to bed from 6pm until 7am Thursday. Woke up Thursday much better besides a small headache.
At the end of February I was short of breath and had some chest pain. I went to see my doctor and they did cardiac workup which really did not show much, an echocardiogram which showed evidence of pulmonary hypertension, then I had a referral to pulmonology and they did a chest CAT scan and discovered multiple blood clots in both lungs.  They prescribed Eliquis. I am still a little bit out of breath.
Pt developed a rash over entire body 1APR91, temp 103 2APR91; Seen by MD- 3APR91 inflammed throat put on Amoxicillin 1 tsp 3 x a day;
Pt states where he had his pneumonia shot was the size of a dollar. He felt achy all over (from neck to his knees) states that area is hard and very sore. Advised to continue to take OTC pain reliever, massage the area and seek ER for any difficulty in breathing. 11/14/2010 went to ED w/cellulitis. BACTRIM DS, NORCO prescribed. Stop KEFLEX. Return to ED for fever, increased pain.
Systemic: Fainting / Unresponsive-Moderate, Systemic: Nausea-Moderate, Systemic: Patient became Rigid all over-Moderate
Intermittent SOB 5 days after the first dose; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 61-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 24Apr2021 (at the age of 61-years-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 15May2021 (Saturday), the patient received the second dose of bnt162b2. On 29Apr2021, the patient experienced intermittent sob 5 days after the first dose. Shortness of breath started getting severe on the following monday (unspecified date), worsened on tuesday (unspecified date), went to ED on Wednesday. He was diagnosed with CHF and experienced being unable to breathe when laying back in a chair and having to stop 5-6 times during a 1 mile walk due to the shortness of breath. He had been referred to a cardiologist. Caller had told there was a Pfizer program that can underwrite the cost of his treatment since it is related to the adverse event. The clinical outcome of the intermittent SOB 5 days after the first dose was unknown.  Information on the lot/batch number has been requested.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 08-MAR-2013 at 10:00 am. the patient was vaccinated with VAQTA (lot # 0273AE and expiration date 06-DEC-2014) (dose, therapy route and anatomical location unspecified). The physician reported that VAQTA was exposed to multiple low temperature excursions. excursion time at -1:62:50 hours (also reported as 17 hours, 238 hours at 2 admin). The patient was not experiencing any known symptoms. This is one of several reports from the same source. Additional information has been requested.
Nose bleed 4/20/21, noticed some loss of balance 5/5/2021, complete loss of hearing in right ear accompanied by balance issues and motion sickness
looks like little welts on arms and neck; Eyes are itchy; inside of mouth and lips feels like thrush; lips feel a little swollen; rash on her arms; didn't feel great for a couple days; This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (didn't feel great for a couple days), URTICARIA (looks like little welts on arms and neck), EYE PRURITUS (Eyes are itchy), ORAL CANDIDIASIS (inside of mouth and lips feels like thrush) and LIP SWELLING (lips feel a little swollen) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 013M20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD. Concomitant products included SALBUTAMOL SULFATE (INHALERIN) for COPD, METOPROLOL and PARACETAMOL (TYLENOL) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced MALAISE (didn't feel great for a couple days). On an unknown date, the patient experienced URTICARIA (looks like little welts on arms and neck), EYE PRURITUS (Eyes are itchy), ORAL CANDIDIASIS (inside of mouth and lips feels like thrush), LIP SWELLING (lips feel a little swollen) and RASH (rash on her arms). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) for Itching, at an unspecified dose and frequency. On 12-Feb-2021, MALAISE (didn't feel great for a couple days) had resolved. At the time of the report, URTICARIA (looks like little welts on arms and neck), EYE PRURITUS (Eyes are itchy), ORAL CANDIDIASIS (inside of mouth and lips feels like thrush), LIP SWELLING (lips feel a little swollen) and RASH (rash on her arms) outcome was unknown.            Patient tried Calamine lotion to stop itching on her skin as treatment medication.   This case was linked to US-MODERNATX, INC.-MOD-2021-052047 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-052047:1st dose
Chills, body aches, severe headache, nausea, vomiting, fatigue, pain at injection site over the course of 8 hours.  Vomiting has stopped.  Chills, body aches, headache and fatigue continues although not as severe.
Area of erythema approx. 10cm x8cm with satellite are approx. 2 cm beyond the inner red area.   Warm to the touch, not raised, blanches easily.   Told to monitor and take claritin or allegra OTC.
Dtap was given in right deltoid. Two days later pt complaining of arm pain. Right deltoid swollen, warm to touch, and red. Mom gave Tylenol 9/14/04 for fevers.
Patient receives Menveo in Left Deltoid and Bexsero in R Deltoid at 10:45 am. Walks to front to checkout with mother. Patient collapses into wall and lands on laminate floor @ 10:50. 911 called immediately.  Mother stays at patient side. Patient eyes are dilated and arms stiff for approximately 1 min 30 seconds, patient looses bladder control. EMT arrives. Patient arouses. Ambulance takes patient to ER for further evaluation per mother's request.
vertigo; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing), notes: I have had the COVID. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose: 1), for covid-19 Immunization. The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "vertigo". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient had both shots but after patient took second shot patient got the vertigo. Consumer stated, had the COVID and had both shots.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Chilblains/Covid Toes; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EL9261, Expiration Date: not reported), via an unspecified route of administration, administered in left arm on 10Feb2021 at 16:00 (at the age of 71 years old) as a single dose for COVID-19 immunisation in a hospital. Medical history included Raynaud's Syndrome (self-diagnosed because fingers turn white when cold/discussed with dermatologist) from an unknown date. The patient was not pregnant and was not diagnosed with COVID-19 prior the vaccination. The patient's concomitant medications were not reported. It was reported that patient did not have other vaccine in four weeks. On 13Feb2021, 3 days after being vaccinated, the patient developed very swollen, red toes on one foot (right) and was diagnosed as Chilblains/Covid Toes. Events resulted in doctor or other healthcare professional office/clinic visit wherein therapeutic measure was given in response with the events which included Clobetasol Propionate Ointment. The patient was not tested for COVID-19 after vaccination. The patient was recovering from the event.
Period cycle went completely crazy after getting the vaccine and had period for 4 weeks straight, one week off, 2 weeks on, one week off, one week on and so forth; Period for 4 weeks straight; Inappropriate schedule of vaccine administered to Dose 1: 15May2021; Dose 2: 05Jul2021; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Jul2021 at 12:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 respiratory infection. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 at 12:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. On 16Jul2021 at 12:00, the patient experienced period cycle which went completely crazy after getting the vaccine and had period for 4 weeks straight, one week off, 2 weeks on, one week off, one week on and so forth. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events period cycle went completely crazy after getting the vaccine and had period for 4 weeks straight, one week off, 2 weeks on, one week off, one week on and so forth and period for 4 weeks straight were not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
So at around 9pm the evening of my shot, I started feeling feverish so I went to the other room to get my temperature and while I was waiting for my temperature to be recorded, I started to feel lightheaded and I called out for help. I woke up on the floor, I woke up to my roommate and boyfriend standing over me. They were on the phone with 9-1-1. I was out for about a minute and unresponsive. According to them, my arm was flailing and seizure-ish. I went to the ER, I was taken by EMS services. They gave me fluids and ran bloodwork and monitored me. They sent me home, I did have another episode of what I think was an episode of memory loss/passed out. I just remembered waking up in a room alone. I was at the ER for about 4-5 hours. They gave me IV fluids and I don't remember what else, some sort of supplement. It was magnesium oxide they gave me. When I left the ER I was really exhausted, and feverish and gross and I was pretty sick for the remaining two days. I didn't sleep well that night, I had a fever the following day and into the second day upon returning home as well.
Where I got my shot is still sore/arm still sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2), administered in arm, administration date 11Apr2021 (Lot number: EW0161, Expiration Date: 11Apr2021) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 11Apr2021, outcome "not recovered", described as "Where I got my shot is still sore/arm still sore". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: Patient was asking why her arm was still sore as it has been a couple of weeks. She stated it should not be sore after two weeks.  No follow-up attempts are possible. No further information is expected.
High fever 102.7 second day, chills, nausea, aches and pain all over body, sore in mouth.
FLUZONE vaccine administered 10/1/2012 at 4:45 pm. Patient noticed swelling, redness, and mildly tender at injection site on 10/3/2012 mid afternoon.
Patient had breakthrough seizure on 2/5/2021.  Last prior seizure was 5/2020 before starting Keppra.  It is not clear if seizure was related to vaccine.
pt had 10hr of paleness, lethargy & fever >101.5 which occurred 12hr following vax administration;
In observation area, patient reported feeling dizzy, short of breath and confused. He was brought to the observation area where he reporting that he was not able to take his morning insulin. He reported he felt confused and this was typical when he was not able to take his insulin.  He did not know the date or the day of the week. He reported having took anti-viral medications this morning, but not diabetes meds, including Lantus He denied chest pain.  He had a history of open heart surgery/valve replacement in December 2020.  Recommended transfer to Medical Center ED via ambulance for further evaluation.
A week after receiving the COVID vaccine(Moderna) I started developing a red rash on my upper arm surrounding the injection site. The rash has continued to spread in that area since yesterday.